Takeda gets EMA nod for additional subcutaneous administration of Takhzyro in Hereditary Angioedema patients Ruchika Sharma25 Feb 2025 10:30 AM ISTZurich: Takeda has announced that the European Medicines Agency (EMA) has given approval for an additional 2 mL pre-filled pen option for...
Julie Kim to succeed Christophe Weber as CEO of Takeda Ruchika Sharma30 Jan 2025 5:06 PM ISTOsaka: Takeda has announced that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda's...
Takeda gets Japenese nod for Hyqvia 10% SC injection set for Agammaglobulinemia Ruchika Sharma27 Dec 2024 12:32 PM ISTOsaka: Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immune Globulin...
Takeda gets European Commission approval for Fruzaqla for previously treated metastatic Colorectal cancer Ruchika Sharma23 Jun 2024 12:00 PM ISTFRUZAQLA is a selective oral inhibitor of all three VEGF receptors (-1, -2 and -3). VEGFR inhibitors play a pivotal role in blocking tumor...
Takeda announces Phase 3 topline results for Soticlestat in patients with Dravet Syndrome, Lennox-Gastaut Syndrome Ruchika Sharma18 Jun 2024 4:14 PM ISTOsaka: Takeda has announced topline data from its SKYLINE and SKYWAY studies. SKYLINE (TAK-935-3001) was a multicenter, randomized, double-blind...
Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib Ruchika Sharma16 Jun 2024 10:30 AM ISTJapan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...
Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease Ruchika Sharma21 April 2024 10:00 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC)...
Takeda bags accelerated USFDA nod for Iclusig with chemotherapy in adult patients with newly diagnosed Ph+ ALL Ruchika Sharma22 March 2024 11:57 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...
Biological E, Takeda join hands to accelerate access to Dengue Vaccine in endemic areas Ruchika Sharma29 Feb 2024 3:00 PM ISTHyderabad: Takeda and Biological E. Limited (BE), an India-based Vaccines and Pharmaceutical Company, has announced a strategic partnership...
Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis Ruchika Sharma13 Feb 2024 1:30 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...
Takeda Hyqvia gets USFDA nod for Chronic Inflammatory Demyelinating Polyneuropathy Ruchika Sharma17 Jan 2024 3:54 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved HYQVIA [Immune Globulin Infusion 10% (Human) with...
Takeda gets Chinese nod for Livtencity for adults with Post-transplant Cytomegalovirus Refractory to prior therapies Ruchika Sharma26 Dec 2023 10:00 AM ISTOsaka: Takeda has announced that LIVTENCITY (maribavir) has been approved by the National Medical Products Administration (NMPA) of China...
